Semantic search
From FANTOM5_SSTAR
Human (Homo sapiens)
- 10416-106C2 (chronic lymphocytic leukemia (T-CLL) cell line:SKW-3)
- 10417-106C3 (papillotubular adenocarcinoma cell line:TGBC18TKB)
- 10418-106C4 (transitional-cell carcinoma cell line:5637)
- 10419-106C5 (breast carcinoma cell line:MDA-MB-453)
- 10420-106C6 (colon carcinoma cell line:COLO-320)
- 10421-106C7 (adult T-cell leukemia cell line:ATN-1)
- 10422-106C8 (Burkitt's lymphoma cell line:DAUDI)
- 10423-106C9 (choriocarcinoma cell line:BeWo)
- 10425-106D2 (astrocytoma cell line:TM-31)
- 10426-106D3 (epidermoid carcinoma cell line:A431)
- 10427-106D4 (b cell line:RPMI1788)
- 10428-106D5 (anaplastic carcinoma cell line:8305C)
- 10429-106D6 (acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL)
- 10431-106D8 (epidermoid carcinoma cell line:Ca Ski)
- 10432-106D9 (bile duct carcinoma cell line:HuCCT1)
- 10433-106E1 (giant cell carcinoma cell line:Lu99B)
- 10434-106E2 (oral squamous cell carcinoma cell line:Ca9-22)
- 10435-106E3 (Hodgkin's lymphoma cell line:HD-Mar2)
- 10436-106E4 (signet ring carcinoma cell line:Kato III)
- 10437-106E5 (papillary adenocarcinoma cell line:8505C)
- 10438-106E6 (ductal cell carcinoma cell line:KLM-1)
- 10439-106E7 (prostate cancer cell line:PC-3)
- 10441-106E9 (synovial sarcoma cell line:HS-SY-II)
- 10442-106F1 (schwannoma cell line:HS-PSS)
- 10444-106F3 (glioblastoma cell line:A172)
- 10445-106F4
- 10446-106F5
- 10447-106F6
- 10448-106F7 (endometrial stromal sarcoma cell line:OMC-9)
- 10449-106F8 (cord blood derived cell line:COBL-a untreated)
- 10452-106G2 (cord blood derived cell line:COBL-a 24h infection(-C))
- 10453-106G3 (cord blood derived cell line:COBL-a 24h infection)
- 10454-106G4 (chronic myelogenous leukemia cell line:K562)
- 10455-106G5 (acute lymphoblastic leukemia (B-ALL) cell line:BALL-1)
- 10456-106G6
- 10457-106G7 (squamous cell lung carcinoma cell line:LC-1F)
- 10458-106G8
- 10460-106H1
- 10461-106H2
- 10462-106H3
- 10463-106H4 (squamous cell carcinoma cell line:EC-GI-10)
- 10464-106H5 (acute lymphoblastic leukemia (T-ALL) cell line:Jurkat)
- 10466-106H7
- 10467-106H8
- 10468-106H9
- 10470-106I2 (gall bladder carcinoma cell line:TGBC14TKB)
- 10471-106I3 (renal cell carcinoma cell line:TUHR10TKB)
- 10472-106I4
- 10474-106I6 (myeloma cell line:PCM6)
- 10475-106I7 (retinoblastoma cell line:Y79)
- 10476-106I8 (Burkitt's lymphoma cell line:RAJI)
- 10478-107A1
- 10479-107A2
- 10480-107A3
- 10481-107A4
- 10482-107A5 (breast carcinoma cell line:MCF7)
- 10483-107A6 (signet ring carcinoma cell line:NUGC-4)
- 10484-107A7 (hepatoma cell line:Li-7)
- 10485-107A8 (glioblastoma cell line:T98G)
- 10486-107A9 (squamous cell lung carcinoma cell line:EBC-1)
- 10487-107B1 (giant cell carcinoma cell line:LU65)
- 10488-107B2 (ductal cell carcinoma cell line:MIA Paca2)
- 10489-107B3
- 10490-107B4 (prostate cancer cell line:DU145)
- 10491-107B5
- 10492-107B6 (transitional-cell carcinoma cell line:JMSU1)
- 10493-107B7 (mesothelioma cell line:ACC-MESO-1)
- 10494-107B8 (mesothelioma cell line:ACC-MESO-4)
- 10496-107C1 (bile duct carcinoma cell line:TFK-1)
- 10497-107C2 (endometrial carcinoma cell line:OMC-2)
- 10498-107C3
- 10499-107C4 (lung adenocarcinoma cell line:A549)
- 10500-107C5
- 10501-107C6 (squamous cell lung carcinoma cell line:RERF-LC-AI)
- 10502-107C7
- 10503-107C8
- 10504-107C9
- 10505-107D1
- 10506-107D2
- 10507-107D3
- 10508-107D4 (neuroblastoma cell line:CHP-134)
- 10509-107D5 (large cell lung carcinoma cell line:IA-LM)
- 10510-107D6 (osteosarcoma cell line:143B/TK^(-)neo^(R))
- 10511-107D7
- 10512-107D8
- 10513-107D9 (colon carcinoma cell line:CACO-2)
- 10515-107E2
- 10517-107E4
- 10518-107E5
- 10519-107E6
- 10521-107E8
- 10522-107E9
- 10523-107F1
- 10524-107F2
- 10525-107F3
- 10526-107F4
- 10527-107F5
- 10528-107F6
- 10531-107F9
- 10532-107G1
- 10533-107G2
- 10534-107G3 (acute lymphoblastic leukemia (B-ALL) cell line:NALM-6)
- 10536-107G5 (cholangiocellular carcinoma cell line:HuH-28)
- 10537-107G6
- 10538-107G7
- 10539-107G8 (neuroblastoma cell line:NB-1)
- 10540-107G9
- 10541-107H1 (small cell lung carcinoma cell line:LK-2)
- 10542-107H2
- 10543-107H3
- 10544-107H4 (oral squamous cell carcinoma cell line:SAS)
- 10545-107H5 (oral squamous cell carcinoma cell line:HSC-3)
- 10546-107H6
- 10547-107H7
- 10548-107H8
- 10550-107I1 (oral squamous cell carcinoma cell line:HO-1-u-1)
- 10551-107I2
- 10554-107I5
- 10555-107I6 (neuroblastoma cell line:NH-12)
- 10556-107I7
- 10557-107I8
- 10558-107I9 (osteosarcoma cell line:HS-Os-1)
- 10559-108A1
- 10562-108A4 (small cell lung carcinoma cell line:WA-hT)
- 10563-108A5 (xeroderma pigentosum b cell line:XPL 17)
- 10564-108A6
- 10565-108A7
- 10566-108A8
- 10568-108B1 (mesenchymal stem cell line:Hu5/E18)
- 10573-108B6
- 10574-108B7
- 10575-108B8
- 10576-108B9
- 10577-108C1
- 10578-108C2
- 10579-108C3
- 10580-108C4
- 10581-108C5
- 10582-108C6
- 10583-108C7
- 10584-108C8
- 10585-108C9
- 10586-108D1
- 10587-108D2
- 10588-108D3
- 10589-108D4 (argyrophil small cell carcinoma cell line:TC-YIK)
- 10590-108D5 (testicular germ cell embryonal carcinoma cell line:NEC8)
- 10591-108D6 (testicular germ cell embryonal carcinoma cell line:NEC14)
- 10592-108D7
- 10593-108D8 (testicular germ cell embryonal carcinoma cell line:NEC15)
- 10594-108D9
- 10595-108E1
- 10599-108E5
- 10600-108E6 (myxofibrosarcoma cell line:MFH-ino)
- 10601-108E7
- 10607-108F4 (neuroblastoma cell line:NBsusSR)
- 10609-108F6 (small-cell gastrointestinal carcinoma cell line:ECC4)
- 10610-108F7 (small cell gastrointestinal carcinoma cell line:ECC10)
- 10611-108F8
- 10612-108F9 (gastric adenocarcinoma cell line:MKN45)
- 10613-108G1
- 10614-108G2 (gastric adenocarcinoma cell line:MKN1)
- 10615-108G3 (gastrointestinal carcinoma cell line:ECC12)
- 10616-108G4 (squamous cell carcinoma cell line:T3M-5)
- 10617-108G5
- 10618-108G6 (choriocarcinoma cell line:T3M-3)
- 10619-108G7
- 10620-108G8
- 10621-108G9
- 10623-108H2
- 10624-108H3 (granulosa cell tumor cell line:KGN)
- 10625-108H4
- 10627-108H6
- 10628-108H7
- 10629-108H8
- 10630-108H9
- 10631-108I1 (diffuse large B-cell lymphoma cell line:CTB-1)
- 10632-108I2
- 10633-108I3 (hepatoblastoma cell line:HuH-6)
- 10634-108I4
- 10635-108I5
- 10636-108I6 (clear cell carcinoma cell line:TEN)
- 10638-108I8 (clear cell carcinoma cell line:JHOC-5)
- 10639-108I9 (serous adenocarcinoma cell line:JHOS-2)
- 10640-109A1
- 10641-109A2
- 10642-109A3 (carcinosarcoma cell line:JHUCS-1)
- 10643-109A4 (endometrioid adenocarcinoma cell line:JHUEM-1)
- 10644-109A5
- 10645-109A6
- 10646-109A7 (squamous cell carcinoma cell line:JHUS-nk1)
- 10647-109A8 (lens epithelial cell line:SRA 01/04)
- 10648-109A9 (mucinous adenocarcinoma cell line:JHOM-1)
- 10649-109B1
- 10650-109B2
- 10651-109B3
- 10652-109B4
- 10653-109B5
- 10656-109B8
- 10658-109C1
- 10659-109C2
- 10660-109C3
- 10661-109C4
- 10662-109C5
- 10664-109C7
- 10665-109C8
- 10666-109C9
- 10667-109D1
- 10668-109D2
- 10669-109D3
- 10670-109D4
- 10671-109D5
- 10672-109D6
- 10673-109D7
- 10674-109D8
- 10675-109D9
- 10676-109E1
- 10677-109E2
- 10678-109E3
- 10679-109E4
- 10681-109E6
- 10682-109E7
- 10683-109E8
- 10684-109E9 (myxofibrosarcoma cell line:NMFH-1)
- 10685-109F1
- 10688-109F4 (glassy cell carcinoma cell line:HOKUG)
- 10690-109F6
- 10691-109F7 (meningioma cell line:HKBMM)
- 10692-109F8 (large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF)
- 10693-109F9 (serous cystadenocarcinoma cell line:HTOA)
- 10696-109G3 (mesodermal tumor cell line:HIRS-BM)
- 10698-109G5 (pancreatic carcinoma cell line:NOR-P1)
- 10699-109G6 (acute myeloid leukemia (FAB M7) cell line:M-MOK)
- 10700-109G7 (chondrosarcoma cell line:SW 1353)
- 10701-109G8
- 10702-109G9 (basal cell carcinoma cell line:TE 354.T)
- 10703-109H1 (carcinoid cell line:NCI-H1770)
- 10704-109H2 (osteoclastoma cell line:Hs 706.T)
- 10706-109H4 (pleomorphic hepatocellular carcinoma cell line:SNU-387)
- 10707-109H5 (transitional cell carcinoma cell line:Hs 769.T)
- 10708-109H6 (alveolar cell carcinoma cell line:SW 1573)
- 10709-109H7 (bronchioalveolar carcinoma cell line:NCI-H358)
- 10710-109H8 (bronchogenic carcinoma cell line:ChaGo-K-1)
- 10711-109H9 (fibrous histiocytoma cell line:GCT TIB-223)
- 10712-109I1 (hairy cell leukemia cell line:Mo)
- 10714-109I3
- 10715-109I4 (bronchioalveolar carcinoma cell line:NCI-H650)
- 10716-109I5
- 10717-109I6 (acantholytic squamous carcinoma cell line:HCC1806)
- 10718-109I7 (biphenotypic B myelomonocytic leukemia cell line:MV-4-11)